Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Ahmedabad, India | Makes it and tests it | No problems foundFeb 14, 2025 · 4 inspections |
Recalls
- Dec 10, 2024 · Class II · Viona Pharmaceuticals Inc
Crystallization
Lots: Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026. - Dec 10, 2024 · Class II · Viona Pharmaceuticals Inc
Crystallization
Lots: Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026 - Oct 29, 2024 · Class II · Viona Pharmaceuticals Inc
Crystallization
Lots: Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026 - Sep 24, 2024 · Class II · Viona Pharmaceuticals Inc
Crystallization
Lots: Lot #: T400512, Exp 02/28/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dapsone: every company that makes it
- Form
- gel, topical
- Strength
- 75 mg per 1 g
- Approval
- ANDA ANDA214019
- On the market since
- May 10, 2024
- Package NDCs
72578-094-0172578-094-0272578-094-03- Official label
- DailyMed (National Library of Medicine), updated May 11, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?